Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Signorelli

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
Targeted Oncology|April 13, 2024
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective AnalysisMichele Basso, Carlo Signorelli, Maria Alessandra Calegari, et al.
Acta Bio-Medica : Atenei Parmensis|October 27, 2022
Transforming waiting pauses into opportunity for physical activity: the "Activate your Wait" pilot studyCesira Pasquarella, Assunta Bizzarro, Rosamaria Martini, et al.
Acta Bio-Medica : Atenei Parmensis|April 11, 2020
["Activate your Wait" project : pilot study carried out at a thermal centre]Cesira Pasquarella, Assunta Bizzarro, Rosamaria Martini, et al.
Environmental Health : a Global Access Science Source|August 31, 2017
Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosisMarco Vinceti, Tommaso Filippini, Federica Violi, et al.
Scandinavian Journal of Medicine & Science in Sports|September 17, 2022
Daily patterns of physical activity, sedentary behavior, and prevalent and incident depression-The Maastricht StudyVincenza Gianfredi, Nicolaas C Schaper, Anna Odone, et al.
Cancer Medicine|October 18, 2016
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr StudyCarmine Pinto, Francesca Di Fabio, Gerardo Rosati, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective StudyCarlo Signorelli, Maria Alessandra Calegari, Michele Basso, et al.
Clinical Colorectal Cancer|January 24, 2025
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter CohortJessica Lucchetti, Lorenzo Angotti, Alessandro Parisi, et al.
Cancers|December 23, 2023
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup AnalysisCarlo Signorelli, Mario Giovanni Chilelli, Diana Giannarelli, et al.
Journal of Physical Activity & Health|March 22, 2016
Investigating the Role of Physical Education in Physical Activity Promotion: An Italian Multicenter StudyFrancesca Gallè, Valeria Di Onofrio, Fabio Barbone, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Targeted Oncology|April 13, 2024
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective AnalysisMichele Basso, Carlo Signorelli, Maria Alessandra Calegari, et al.
Acta Bio-Medica : Atenei Parmensis|October 27, 2022
Transforming waiting pauses into opportunity for physical activity: the "Activate your Wait" pilot studyCesira Pasquarella, Assunta Bizzarro, Rosamaria Martini, et al.
Acta Bio-Medica : Atenei Parmensis|April 11, 2020
["Activate your Wait" project : pilot study carried out at a thermal centre]Cesira Pasquarella, Assunta Bizzarro, Rosamaria Martini, et al.
Environmental Health : a Global Access Science Source|August 31, 2017
Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosisMarco Vinceti, Tommaso Filippini, Federica Violi, et al.
Scandinavian Journal of Medicine & Science in Sports|September 17, 2022
Daily patterns of physical activity, sedentary behavior, and prevalent and incident depression-The Maastricht StudyVincenza Gianfredi, Nicolaas C Schaper, Anna Odone, et al.
Cancer Medicine|October 18, 2016
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr StudyCarmine Pinto, Francesca Di Fabio, Gerardo Rosati, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective StudyCarlo Signorelli, Maria Alessandra Calegari, Michele Basso, et al.
Clinical Colorectal Cancer|January 24, 2025
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter CohortJessica Lucchetti, Lorenzo Angotti, Alessandro Parisi, et al.
Cancers|December 23, 2023
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup AnalysisCarlo Signorelli, Mario Giovanni Chilelli, Diana Giannarelli, et al.
Journal of Physical Activity & Health|March 22, 2016
Investigating the Role of Physical Education in Physical Activity Promotion: An Italian Multicenter StudyFrancesca Gallè, Valeria Di Onofrio, Fabio Barbone, et al.
Pageof 30